Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
    Research Site
    Danbury, Connecticut
    Thyroid Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Yale Cancer Center
    Hospital of Saint Raphael
    Norwalk Hospital
    Connecticut Oncology & Hematology - Torrington
    Breast Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Connecticut

    Trial Locations
    University of Connecticut
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Colorectal Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Lymphoma
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Middlesex Hospital
    Middletown, Connecticut 06457
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Nonmalignant Neoplasm
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Connecticut Health Care System (West Haven)
    West Haven, Connecticut 06516
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    Middlesex Hospital Cancer Center
    Connecticut Oncology & Hematology - Torrington
    Metastatic Cancer, Prostate Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    George Bray Cancer Center/New Britain General Hospital

    Trial Locations
    George Bray Cancer Center/New Britain General Hospital
    Oncology and Hematology Associates, PC
    Whittingham Cancer Center at Norwalk Hospital
    Hematology/Oncology PC/Carl and Dorothy Bennet Cancer Center
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Connecticut Gastroenterology Consultants
    New Haven, Connecticut 06510
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Lymphoma, T-Cell, Peripheral
    Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
    Grove Hill Medical Center Urology
    New Britain, Connecticut 06052
    Metastatic Prostate Cancer
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital

    Trial Locations
    Helen and Harry Gray Cancer Center at Hartford Hospital
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Pancreatic Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Norwich, Connecticut 06360
    Non-Hodgkin's Lymphoma
    PhII ICb With/Without Erbitux in MBC Pts
    Northwestern Connecticut Oncology Hematology Associates
    New Milford, Connecticut 06776
    Metastatic Breast Cancer
    High-Dose Periop Statins for Prevention of DVT
    Yale-New Haven Hospital
    New Haven, Connecticut 06504
    Gynecologic Oncological Pelvic/Abdominal Surgery
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Yale University
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    The Hospital of Central Connecticut
    Yale University
    Norwalk Hospital
    Stamford Hospital
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer